The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry

Author:

Buckstein Rena12ORCID,Chodirker Lisa12,Yee Karen W.L.23ORCID,Geddes Michelle4ORCID,Leitch Heather A.5ORCID,Christou Grace6ORCID,Banerji Versha7ORCID,Leber Brian8,Khalaf Dina8,St-Hilaire Eve9,Finn Nicholas9,Nevill Thomas10ORCID,Keating Mary-Margaret11,Storring John12,Parmentier Anne1ORCID,Thambipillai Aksharh1,Tang Derek13,Westcott Christopher14,Cameron Chris15ORCID,Spin Paul15ORCID

Affiliation:

1. Division of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada

2. Department of Medicine, University of Toronto, Toronto, Canada

3. Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

4. Department of Medicine, Tom Baker Cancer Centre, Calgary, Canada

5. Division of Hematology, St. Paul’s Hospital, University of British Columbia, Vancouver, Canada

6. Clinical epidemiology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada

7. CancerCare Manitoba Foundation, Winnipeg, Canada

8. Hematology Disease Site Team, Juravinski Cancer Centre, Hamilton Health Sciences, Hamilton, Canada

9. Hematology Services, Centre Hospitalier Universitaire Dr. Georges-L.-Dumont, Moncton, Canada

10. Division of Hematology, Leukemia/Bone Marrow Transplant Program of BC, BC Cancer, University of British Columbia, Vancouver, Canada

11. Division of Hematology, Dalhousie University, Halifax, Canada

12. Hematology Division, McGill University Health Centre, Montréal, Canada

13. Bristol Myers Squibb, Princeton, NJ, USA

14. Celgene Inc., a Bristol-Myers Squibb Company, Mississauga, Canada

15. Value and Evidence Division, Marketing and Market Access, EVERSANA™, Sydney, Canada

Funder

Bristol Myers Squibb

Celgene Inc., a Bristol-Myers Squibb Company, Canada

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3